Federica Fogacci

6.4k total citations
149 papers, 4.0k citations indexed

About

Federica Fogacci is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Federica Fogacci has authored 149 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Surgery, 42 papers in Cardiology and Cardiovascular Medicine and 35 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Federica Fogacci's work include Lipoproteins and Cardiovascular Health (35 papers), Gout, Hyperuricemia, Uric Acid (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers). Federica Fogacci is often cited by papers focused on Lipoproteins and Cardiovascular Health (35 papers), Gout, Hyperuricemia, Uric Acid (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers). Federica Fogacci collaborates with scholars based in Italy, United States and Poland. Federica Fogacci's co-authors include Arrigo F.G. Cicero, Claudio Borghi, Marina Giovannini, Alessandro Colletti, Marilisa Bove, Sergio D’Addato, Maciej Banach, L. M. Strilchuk, Elisa Grandi and Peter P. Tóth and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Federica Fogacci

136 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federica Fogacci Italy 38 1.1k 946 690 589 537 149 4.0k
Hidekatsu Yanai Japan 28 722 0.7× 879 0.9× 927 1.3× 319 0.5× 359 0.7× 174 3.7k
Azar Baradaran Iran 30 466 0.4× 780 0.8× 709 1.0× 279 0.5× 385 0.7× 162 3.8k
Hamid Nasri Iran 38 654 0.6× 1.0k 1.1× 1.2k 1.7× 455 0.8× 952 1.8× 350 6.1k
Zipora Matas Israel 33 481 0.4× 557 0.6× 479 0.7× 599 1.0× 553 1.0× 68 3.3k
Anna Gluba-Brzózka Poland 29 567 0.5× 692 0.7× 496 0.7× 541 0.9× 677 1.3× 89 3.0k
Hélder Mota‐Filipe Portugal 38 558 0.5× 1.7k 1.8× 401 0.6× 290 0.5× 640 1.2× 101 4.7k
Davide Grassi Italy 35 406 0.4× 608 0.6× 660 1.0× 675 1.1× 257 0.5× 92 4.5k
Natalie C. Ward Australia 42 784 0.7× 1.4k 1.5× 881 1.3× 877 1.5× 135 0.3× 129 5.5k
Felipe Javier Chaves Spain 36 641 0.6× 1.3k 1.4× 706 1.0× 631 1.1× 217 0.4× 205 4.6k
Choon Hee Chung South Korea 39 560 0.5× 1.4k 1.5× 1.3k 1.9× 269 0.5× 722 1.3× 178 4.4k

Countries citing papers authored by Federica Fogacci

Since Specialization
Citations

This map shows the geographic impact of Federica Fogacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Fogacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Fogacci more than expected).

Fields of papers citing papers by Federica Fogacci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Fogacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Fogacci. The network helps show where Federica Fogacci may publish in the future.

Co-authorship network of co-authors of Federica Fogacci

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Fogacci. A scholar is included among the top collaborators of Federica Fogacci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Fogacci. Federica Fogacci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fogacci, Federica, Ashot Avagimyan, Marco Bernardi, et al.. (2025). The effect of highly bioavailable forms of curcumin on lipoprotein(a) plasma levels: A systematic review and meta-analysis of randomized clinical studies. Prostaglandins & Other Lipid Mediators. 178. 106994–106994. 2 indexed citations
2.
Fogacci, Federica, et al.. (2025). Reprogramming the Mitochondrion in Atherosclerosis: Targets for Vascular Protection. Antioxidants. 14(12). 1462–1462.
3.
Banach, Maciej, Federica Fogacci, Atanas G. Atanasov, et al.. (2025). A 360° Perspective on Cardiovascular Prevention: the International Lipid Expert Panel SiMple tIps for the heaLthy hEart (ILEP-SMILE). Archives of Medical Science. 21(3). 711–718. 2 indexed citations
4.
Cicero, Arrigo F.G., et al.. (2024). Efficacy and Safety of Low-Dose Bisoprolol/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 13(15). 4572–4572. 1 indexed citations
5.
Medoro, Alessandro, Sergio Davinelli, Federica Fogacci, et al.. (2024). Palmitoylethanolamide in Postmenopausal Metabolic Syndrome: Current Evidence and Clinical Perspectives. Nutrients. 16(24). 4313–4313. 3 indexed citations
6.
Giovannini, Marina, Federica Fogacci, Sergio D’Addato, et al.. (2024). Healthy Eating beyond Whole Grains—Insight on Associations between Diet Quality and Arterial Stiffness in the Brisighella Heart Study Cohort. Nutrients. 16(16). 2792–2792.
8.
Fogacci, Federica, et al.. (2024). Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety. Nutrients. 16(10). 1526–1526. 3 indexed citations
9.
Fogacci, Federica, Kausik K. Ray, Stephen J. Nicholls, & Arrigo F.G. Cicero. (2024). Reducing the global prevalence of cardiometabolic risk factors: a bet worth winning. Metabolism. 163. 156084–156084. 4 indexed citations
10.
Kennedy, Cormac, et al.. (2023). The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 12(3). 772–772. 26 indexed citations
11.
Cicero, Arrigo F.G., et al.. (2023). Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential. International Journal of Molecular Sciences. 24(8). 7027–7027. 41 indexed citations
12.
13.
Cicero, Arrigo F.G., Federica Fogacci, Anca Pantea Stoian, & Peter P. Tóth. (2023). Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review. Nutrients. 15(10). 2288–2288. 24 indexed citations
14.
Cicero, Arrigo F.G., Federica Fogacci, Sergio D’Addato, et al.. (2023). Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study. Nutrients. 15(2). 312–312. 10 indexed citations
16.
Cicero, Arrigo F.G., et al.. (2022). Short-term evolocumab-induced tendon xanthomas regression in an elderly patient with homozygous familial hypercholesterolemia. Internal and Emergency Medicine. 18(1). 307–310.
17.
Cicero, Arrigo F.G., Roberto Pontremoli, Federica Fogacci, Francesca Viazzi, & Claudio Borghi. (2020). Effect of Bempedoic Acid on Serum Uric Acid and Related Outcomes: A Systematic Review and Meta-analysis of the available Phase 2 and Phase 3 Clinical Studies. Drug Safety. 43(8). 727–736. 37 indexed citations
18.
Fogacci, Federica, Nicola Ferri, Peter P. Tóth, et al.. (2019). Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Drugs. 79(7). 751–766. 98 indexed citations
19.
Cicero, Arrigo F.G., Alessandro Colletti, Federica Fogacci, et al.. (2018). Is it Possible to Significantly Modify Blood Pressure with a Combined Nutraceutical on Top of a Healthy Diet? The Results of a Pilot Clinical Trial. High Blood Pressure & Cardiovascular Prevention. 25(4). 401–405. 7 indexed citations
20.
Cicero, Arrigo F.G., Federica Fogacci, & Alessandro Colletti. (2018). Commentary to: “The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials”. High Blood Pressure & Cardiovascular Prevention. 25(1). 51–52. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026